Index des conférences Vidéos des conférences
Index des revues Couvertures des revues S'abonner Commander un numéro précis Caricatures Proposez un texte
Dictionnaire Sceptique Quackwatch Chroniques SdQ Argumentaires Émissions télé québécoises Sites sceptiques recommandés Suggestions de lecture
Le début de l'association Mission et rôle Devenir membre Faire un don Foire aux questions Administration Prix sceptique Boutique

LES SCEPTIQUES DU QUÉBEC

quackwatch

"Thérapie de libération" pour la sclérose en plaques

Dr Stephen Barrett

 

https://www.quackwatch.org/08Misc/zamboni/overview.html (article à traduire)

 

Dr Paolo Zamboni

Dr Paolo Zamboni

 

Références

  1. Zamboni P and others. A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency. Journal of Vascular Surgery 50:1348-1358, 2009.
  2. Tullis P. Controversial 'cure' for M.S. The New York Times, Oct 6, 2012.
  3. Traboulsee AL and others. Prevalence of extracranial venous narrowing on catheter venography in people with multiple sclerosis, their siblings, and unrelated healthy controls: a blinded, case-control study. The Lancet 383:138-145, 2014.
  4. Martin N and others. Prevalence of extracranial venous narrowing on magnetic resonance venography is similar in people with multiple sclerosis, their siblings, and unrelated healthy controls: a blinded, case-control study. Canadian Association of Radiology Journal 68:202-209, 2017.
  5. Amos H. Controversial "liberation therapy" fails to treat multiple sclerosis: study. University of British Columbia News, March 8, 2017.
  6. Zamboni P and others. Efficacy and safety of extracranial vein angioplasty in multiple sclerosis: A randomized clinical trial. JAMA Neurology, Nov 18, 2017.
  7. Novella S. Liberation procedure for multiple sclerosis: The final chapter. Neurologica Blog, Dec 1, 2017.
  8. Chronic cerebrospinal venous insufficiency treatment in multiple sclerosis patients. FDA safety alert, May 12, 2012.
  9. FDA concern over experimental procedures that use balloon angioplasty devices to treat autonomic dysfunction: FDA safety communication, March 8, 2017.
  10. Michael A. Arata, M.D. Synergy Health Concepts Web site, accessed May 2, 2018.
  11. Newman RW. Notice of initiation of disqualification proceedings. Sept 13, 2016.
  12. Plaisier MK. Follow-up letter offering a regulatory hearing. June 21, 2017.
  13. Silverman SD. Letter to James F. McGuckin, Jr., M.D., April 11, 2013.
  14. Statement of charges. In the matter of the license to practice as a physician and surgeon of James F. McGuckin, MD. State of Washington Medical Quality Assurance Commission, Case No. M2013-185, Nov 25, 2014.
  15. Stipulated findings of fact, conclusions of law, and agreed order. In the matter of the license to practice as a physician and surgeon of James F. McGuckin, MD. State of Washington Medical Quality Assurance Commission, Case No. M2013-185, Oct 1, 2015.
  16. Farber J and others. From hope to medical nightmare: Despite FDA warnings, state boards lag in taking action on controversial MS treatment. Milwaukee Journal Sentinel, March 25, 2018.
  17. La «thérapie par libération», proposée par le Dr Paolo Zamboni, ne permet pas de traiter la sclérose en plaques. - Santé Montréal
  18. Sclérose en plaques : la thérapie de libération de Zamboni est inefficace, Psychomédia
  19. La « thérapie de libération » est inefficace contre la sclérose en plaques, par Jacqueline Charpentier.
  20. Les résultats d’un essai clinique confirment l’inefficacité de la veinoplastie pour le traitement de la sclérose en plaques.

Dernière mise à jour le 21 janvier 2020.

Source: Quackwatch